These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22212561)

  • 21. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.
    Matthews LT; Ribaudo HB; Kaida A; Bennett K; Musinguzi N; Siedner MJ; Kabakyenga J; Hunt PW; Martin JN; Boum Y; Haberer JE; Bangsberg DR
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):399-406. PubMed ID: 26495883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
    Myer L; Kamkuemah M; Kaplan R; Bekker LG
    Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa.
    Hoffmann CJ; Cohn S; Mashabela F; Hoffmann JD; McIlleron H; Denti P; Haas DW; Dooley KE; Martinson NA; Chaisson RE
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):31-7. PubMed ID: 26334739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.
    Pilotto JH; Velasque LS; Friedman RK; Moreira RI; Veloso VG; Grinsztejn B; Morgado MG; Watts DH; Currier JS; Hoffman RM
    Antivir Ther; 2011; 16(3):349-56. PubMed ID: 21555817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virological profile of pregnant HIV positive women with high levels of CD4 count in low income settings: can viral load help as eligibility criteria for maternal triple ARV prophylaxis (WHO 2010 option B)?
    Njom Nlend AE; Same Ekobo C; Moyo ST; Nguetcheng GC; Ngang P; Lyeb S; Meka L; Baane M
    Pan Afr Med J; 2011; 10():27. PubMed ID: 22187609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral therapeutic drug monitoring in HIV-infected pregnant women: maternal immunovirological outcome at delivery and during the 18 month follow-up period.
    Nicastri E; Ivanovic J; Signore F; Tempestilli M; Bellagamba R; Viscione M; Pisani G; Vallone C; Tommasi C; Gallo AL; De Nardo P; Pucillo PL; Narciso P
    Curr HIV Res; 2012 Oct; 10(7):606-13. PubMed ID: 22762419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to first viral load testing among pregnant women living with HIV initiated on option B+ at 5 government clinics in Kampala city, Uganda: Retrospective cohort study.
    Atuhaire P; Matovu F; Nakalega R; Kataike H; Nabwana M; Lukyamuzi Z; Guwattude D
    Int J Infect Dis; 2021 Mar; 104():526-531. PubMed ID: 33434664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience of nevirapine use in a London cohort of HIV-infected pregnant women.
    Edwards SG; Larbalestier N; Hay P; de Ruiter A; Welch J; Taylor GP; Easterbrook P
    HIV Med; 2001 Apr; 2(2):89-91. PubMed ID: 11737384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa.
    Naicker N; Yende-Zuma N; Kharsany ABM; Shozi H; Nkosi D; Naidoo A; Garrett N; Abdool Karim SS
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):596. PubMed ID: 35883114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.
    Rupérez M; Noguera-Julian M; González R; Maculuve S; Bellido R; Vala A; Rodríguez C; Sevene E; Paredes R; Menéndez C
    PLoS One; 2018; 13(5):e0196451. PubMed ID: 29742132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine.
    Ekpini RA; Nkengasong JN; Sibailly T; Maurice C; Adjé C; Monga BB; Roels TH; Greenberg AE; Wiktor SZ
    AIDS; 2002 Mar; 16(4):625-30. PubMed ID: 11873007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.
    Hoffman RM; Angelidou KN; Brummel SS; Saidi F; Violari A; Dula D; Mave V; Fairlie L; Theron G; Kamateeka M; Chipato T; Chi BH; Stranix-Chibanda L; Nematadzira T; Moodley D; Bhattacharya D; Gupta A; Coletti A; McIntyre JA; Klingman KL; Chakhtoura N; Shapiro DE; Fowler MG; Currier JS;
    HIV Clin Trials; 2018 Dec; 19(6):209-224. PubMed ID: 30890061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.
    Tukei VJ; Murungi M; Asiimwe AR; Migisha D; Maganda A; Bakeera-Kitaka S; Kalyesubula I; Musoke P; Kekitiinwa A
    BMC Pediatr; 2013 Mar; 13():42. PubMed ID: 23536976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
    Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
    J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.